Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy

Physics in Medicine and Biology

Volumn 55, Issue 12, 2010, Pages 3451-3465

  Haar, Peter J ^a   Broaddus, William C ^b   Chen, Zhi Jian ^b   Fatouros, Panos P ^a   Gillies, George T ^b,c   Corwin, Frank D ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Virginia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUEOUS SOLUTIONS; BRAIN RESEARCH; BRAIN SLICES; BRAIN TISSUE; CEREBRO SPINAL FLUIDS; CONTRAST AGENT; CONTRAST CHANGES; CONVECTION-ENHANCED DELIVERY; DEGREE OF COINCIDENCE; EXTRACELLULAR SPACE; GD-DTPA; ICP-AES; INDUCTIVELY COUPLED PLASMA ATOMIC EMISSION SPECTROSCOPY; NON-INVASIVE; RAT BRAIN; RELAXIVITY; TIME POINTS; TISSUE CONCENTRATIONS;

ATOMIC EMISSION SPECTROSCOPY; ATOMIC SPECTROSCOPY; BODY FLUIDS; BRAIN; CONCENTRATION (PROCESS); ELECTROMAGNETIC INDUCTION; INDUCTIVELY COUPLED PLASMA; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING;

GADOLINIUM;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ANIMAL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BRAIN; CYTOLOGY; EXTRACELLULAR SPACE; MALE; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; SPRAGUE DAWLEY RAT; THERMODYNAMICS;

ANIMALS; BRAIN; CONTRAST MEDIA; CONVECTION; EXTRACELLULAR SPACE; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MALE; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ATOMIC;

EID: 77954170619     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/55/12/012     Document Type: Article

References (47)

1. Adding L C, Bannenberg G L and Gustafsson L E 2001 Basic experimental studies and clinical aspects of gadolinium salts and chelates Cardiovasc. Drug Rev. 19 41-56
2. Ahrens E T, Rothbacher U, Jacobs R E and Fraser S E 1998 A model for MRI contrast enhancement using T1 agents Proc. Natl Acad. Sci. USA 95 8443-8
3. s NMR Biomed. 16 252-6
4. Armitage F E, Richardson D E and Li K C 1990 Polymeric contrast agents for magnetic resonance imaging: synthesis and characterization of gadolinium diethylenetriaminepentaacetic acid conjugated to polysaccharides Bioconjug. Chem. 1 365-74
5. Bashir A, Gray M L, Hartke J and Burstein D 1999 Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI Magn. Reson. Med. 41 857-65
6. Bilgen M, Dogan B and Narayana P A 2002 In vivo assessment of blood-spinal cord barrier permeability: serial dynamic contrast enhanced MRI of spinal cord injury Magn. Reson. Imaging 20 337-41
7. Bilgen M and Narayana P A 2001 A pharmacokinetic model for quantitative evaluation of spinal cord injury with dynamic contrast-enhanced magnetic resonance imaging Magn. Reson. Med. 46 1099-106
8. Bloch F 1942 Nuclear induction Phys. Rev. 70 460-4742
9. Bloembergen N 1957 Proton relaxation times in paramagnetic solutions J. Chem. Phys. 27 572-3
10. Bloembergen N, Purcell E and Pound R 1948 Relaxation effects in nuclear magnetic resonance absorption Phys. Rev. 73 679-712
11. Bobo R H, Laske D W, Akbasak A, Morrison P F, Dedrick R L and Oldfield E H 1994 Convection-enhanced delivery of macromolecules in the brain Proc. Natl Acad. Sci. USA 91 2076-80
12. Brasch R C 1993 Introduction to the gadolinium class J. Comput. Assist. Tomogr. 17 (Suppl. 1) S14-8
13. Brasch R C, Moseley M E, Dupon J, Wang S C, Aicher K P, Wikstrom M, Schmiedl U, Wolfe C L, Ogan M D and Grood W 1990 Macromolecular magnetic resonance imaging contrast media. Accumulated experience Invest. Radiol. 25 (Suppl. 1) S51-2
14. Bremerich J, Colet J M, Giovenzana G B, Aime S, Scheffler K, Laurent S, Bongartz G and Muller R N 2001 Slow clearance gadolinium-based extracellular and intravascular contrast media for three-dimensional MR angiography J. Magn. Reson. Imaging 13 588-93
15. Broaddus W C, Prabhu S S, Gillies G T, Neal J, Conrad W S, Chen Z J, Fillmore H and Young H F 1998 Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion J. Neurosurg. 88 734-74
16. Diehl K H, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, Vidal J M and van de Vorstenbosch C 2001 A good practice guide to the administration of substances and removal of blood, including routes and volumes J. Appl. Toxicol. 21 15-23
17. Donahue K M, Burstein D, Manning W J and Gray M L 1994 Studies of Gd-DTPA relaxivity and proton exchange rates in tissue Magn. Reson. Med. 32 66-76
18. Fritz-Hansen T, Rostrup E, Ring P B and Larsson H B W 1998 Quantification of gadolinium-DTPA concentrations for different inversion times using an IR-turbo flash pulse sequence: a study on optimizing multislice perfusion imaging Magn. Reson. Imaging 16 893-9
19. Gadian D G, Payne J A, Bryant D J, Young I R, Carr D H and Bydder G M 1985 Gadolinium-DTPA as a contrast agent in MR imaging-theoretical projections and practical observations J. Comput. Assist. Tomogr. 9 242-251
20. Gillis A, Gray M and Burstein D 2002 Relaxivity and diffusion of gadolinium agents in cartilage Magn. Reson. Med. 48 1068-71
21. Haar P J, Stewart J E, Gillies G T, Prabhu S S and Broaddus W C 2001 Quantitative three-dimensional analysis and diffusion modeling of oligonucleotide concentration after direct intraparenchymal brain infusion IEEE Trans. Biomed. Eng. 48 560-9
22. Ishimori Y, Kimura H, Uematsu H, Matsuda T and Itoh H 2003 Dynamic T1 estimation of brain tumors using double-echo dynamic MR imaging J. Magn. Reson. Imaging 18 113-20
23. Kenney P J, Sobol W T, Smith J K and Morgan D E 1997 Computed model of gadolinium enhanced MRI of breast disease Eur. J. Radiol. 24 109-19
24. Koenig S H 1991 From the relaxivity of Gd(DTPA)2- to everything else Magn. Reson. Med. 22 183-90
25. Kornguth S E, Turski P A, Perman W H, Schultz R, Kalinke T, Reale R and Raybaud F 1987 Magnetic resonance imaging of gadolinium-labeled monoclonal antibody polymers directed at human T lymphocytes implanted in canine brain J. Neurosurg. 66 898-906
26. Lai Y L, Smith P M, Lamm W J E and Hildebrandt J 1983 Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats J. Appl. Physiol. 54 1754-7
27. MacKay A, Whittall K, Adler J, Li D, Paty D and Graeb D 1994 In vivo visualization of myelin water in brain by magnetic resonance Magn. Reson. Med. 31 673-7
28. Manabe Y, Longley C and Furmanski P 1986 High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier Biochim. Biophys. Acta 883 460-7
29. Marzola P, et al. 2003 In vivo mapping of fractional plasma volume (fpv) and endothelial transfer coefficient (Kps) in solid tumors using a macromolecular contrast agent: correlation with histology and ultrastructure Int. J. Cancer 104 462-8
30. Mikawa M, Miwa N, Braautigam M, Akaike T and Maruyama A 2000 Gd(3+)-loaded polyion complex for pH depiction with magnetic resonance imaging J. Biomed. Mater. Res. 49 390-5
31. Morkenborg J, Jensen F T, Vaever P N, Frokioer J, Djurhuus J C and Stodkilde-Jorgensen H 1998 In vivo measurement of T1 and T2 relaxivity in the kidney cortex of the pig-based on a two-compartment steady-state model Magn. Reson. Imaging 16 933-42
32. Morkenborg J, Pedersen M, Jensen F T, Stodkilde-Jorgensen H, Djurhuus J C and Frokioer J 2003 Quantitative assessment of Gd-DTPA contrast agent from signal enhancement: an in-vitro study Magn. Reson. Imaging 21 637-43
33. Ogan M D, Schmiedl U, Moseley M E, Grodd W, Paajanen H and Brasch R C 1987 Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization Invest. Radiol. 22 665-71 (Pubitemid 17138432)
34. Pedersen M, Morkenborg J, Jensen F T, Stodkilde-Jorgensen H, Djurhuus J C and Frokioer J 2000 In vivo measurements of relaxivities in the rat kidney cortex J. Magn. Reson. Imaging 12 289-96
35. Reichenbach J R, Hacklander T, Harth T, Hofer M, Rassek M and Modder U 1997 1H T1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5T Eur. Radiol. 7 264-74
36. Runge V M, Jacobson S, Wood M L, Kaufman D and Adelman L S 1988 MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA Radiology 166 835-8
37. Saito R, Bringas J R, McKnight T R, Wendland M F, Mamot C, Drummond D C, Kirpotin D B, Park J W, Berger M S and Bankiewiz K S 2004 Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging Cancer Res. 64 2572-9
38. Schuhmann-Giampieri G and Krestin G 1991 Pharmacokinetics of Gd-DTPA in patients with chronic renal failure Invest. Radiol. 26 975-9
39. Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, Press W R and Weinmann H J 1991 In vivo and in vitro evaluation of Gd-DTPA-polylysine as a macromolecular contrast agent for magnetic resonance imaging Invest. Radiol. 26 969-74
40. Shuter B, Wang S C, Roche J, Briggs G and Pope J M 1998 Relaxivity of Gd-EOB-DTPA in the normal and biliary obstructed guinea pig J. Magn. Reson. Imaging 8 853-61
41. Solomon I 1955 Relaxation processes in a system of two spins Phys. Rev. 99 559-65
42. Stanisz G J and Henkelman R M 2000 Gd-DTPA relaxivity depends on macromolecular content Magn. Reson. Med. 44 665-7
43. Tofts P S 1997 Modeling tracer kinetics in dynamic Gd-DTPA MR imaging J. Magn. Reson. Imaging 7 91-101
44. Tweedle M F, Wedeking P, Telser J, Sotak C H, Chang C A, Kumar K, Wan X and Eaton S M 1991 Dependence of MR signal intensity on Gd tissue concentration over a broad dose range Magn. Reson. Med. 22 191-4
45. VanWagoner M, O'Toole M, Worah D, Leese P T and Quay S C 1991 A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent Invest. Radiol. 26 980-6
46. Wang S C, White D L, Pope J M and Brasch R C 1990 Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration Invest. Radiol. 25 (Suppl. 1) S44-5
47. Weinmann H J, Brasch R C, Press W R and Wesbey G E 1984 Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent AJR Am. J. Roentgenol. 142 619-24